Division of Infectious Diseases participates in the University of Kentucky
Chandler Medical Center’s tripartite mission of providing creative
leadership and quality initiatives in patient care, medical education,
and medical research.
Patient Care Division faculty
are committed to excellence in patient care, and oversee a continuous
quality improvement (CQI) program designed to ensure
high quality care and outcomes. Faculty include hospital epidemiologists
at both the University of Kentucky Hospital and the Lexington Veterans
Affairs Medical Center, and the physicians who staff the Division’s
3 outpatient clinics located in the Kentucky Clinic, adjoining the UK
(2) Infectious Diseases Clinic, under the leadership
of Alice C. Thornton, MD
For more information about Patient Services, click
Education Faculty provide a broad range of educational experiences, from medical
student lectures to continuing education forums. Special programs of the
Infectious Diseases Conferences The following conferences are held regularly:
Infectious Diseases Case Conferences (4/mo)
HIV Case Conferences (1/mo)
HIV Topical Conference (1/mo)
Fellowship Core Conferences (3/mo)
Research Conference (1/mo)
Journal Club Conference (1/mo)
Education and Training Center In its role as the Kentucky AIDS Education and Training Center
(AETC), the Division provides training opportunities and resources
for clinicians statewide who are engaged in the treatment of patients
living with HIV/AIDS under the leadership of
Dr. Alice Thornton.
Fellowship Program Dedicated
to the training of Infectious Diseases physicians and researchers,
the Fellowship Program is led by
Dr. Michael Young For more information about the Fellowship Program, click here.
Division bridges the gap between basic science research and clinical applications
in the treatment of infectious diseases.
Basic science research projects include studies on host immune responses, GPC resistance, physiology of E.
coli heat stable enterotoxin and its family of endogenous human
hormones, including guanylin and uroguanylin (Greenberg) and HIV protease inhibitor toxicity.
Clinical projects include clinical
drug trials, HIV and bioterrorism-related vaccines, Shingles vaccine,
antifungals, C.difficile, West Nile, and HIV
adherence, and risk factors for sexually